首页> 外文期刊>Diabetes >Adenoviral Gene Transfer of the Interleukin-1 Receptor Antagonist Protein to Human Islets Prevents IL-1β-Induced β-Cell Impairment and Activation of Islet Cell Apoptosis In Vitro
【24h】

Adenoviral Gene Transfer of the Interleukin-1 Receptor Antagonist Protein to Human Islets Prevents IL-1β-Induced β-Cell Impairment and Activation of Islet Cell Apoptosis In Vitro

机译:白细胞介素-1受体拮抗剂蛋白向人胰岛的腺病毒基因转移可预防IL-1β诱导的β细胞损伤和胰岛细胞凋亡的激活。

获取原文
获取原文并翻译 | 示例
       

摘要

The β-cells in the pancreatic islets of Langerhans are the targets of autoreactive T-cells and are destroyed in type 1 diabetes. Macrophage-derived interleukin-1β (IL-1β) is important in eliciting β-cell dysfunction and initiating β-cell damage in response to microenviron- mental changes within islets. In particular, IL-1β can impair glucose-stimulated insulin production in β-cells in vitro and can sensitize them to Fas (CD95)/FasL- triggered apoptosis. In this report, we have examined the ability to block the detrimental effects of IL-1β by genetically modifying islets by adenoviral gene transfer to express the IL-1 receptor antagonist protein.
机译:郎格罕氏胰岛中的β细胞是自身反应性T细胞的靶标,在1型糖尿病中被破坏。巨噬细胞源性白介素-1β(IL-1β)在引发β细胞功能异常和响应胰岛内微环境变化引发β细胞损伤中起重要作用。特别是,IL-1β可以在体外损害β细胞中葡萄糖刺激的胰岛素生成,并使它们对Fas(CD95)/ FasL触发的凋亡敏感。在此报告中,我们研究了通过腺病毒基因转移来表达IL-1受体拮抗剂蛋白的遗传修饰胰岛来阻断IL-1β有害作用的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号